President & CEO of Synageva BioPharma Corp (GEVA) Sanj K Patel sells 70,000 shares of GEVA on 09/04/2012 at an average price of $49.47 a share.

Synageva Biopharma Corp has a market cap of $1.06 billion; its shares were traded at around $48.76 with and P/S ratio of 505.6.

CFO Recent Trades:

• SVP, CFO Carsten Boess sold 6,618 shares of GEVA stock on 07/18/2012 at the average price of 48.82. The price of the stock has decreased by 0.12% since.

This is the insider trade history vs. stock price of GEVA. For the complete insider trading history of GEVA, click here.

Directors and Officers Recent Trades:

• Director, 10% Owner Felix Baker bought 886,000 shares of GEVA stock on 07/13/2012 at the average price of 41.2. Felix Baker owns at least 1,736,565 shares after this. The price of the stock has increased by 18.35% since.
• Director, 10% Owner Julian Baker bought 886,000 shares of GEVA stock on 07/13/2012 at the average price of 41.2. Julian Baker owns at least 1,737,085 shares after this. The price of the stock has increased by 18.35% since.
• Director Thomas J Tisch bought 73,000 shares of GEVA stock on 07/12/2012 at the average price of 41.2. Thomas J Tisch owns at least 730,956 shares after this. The price of the stock has increased by 18.35% since.
• SVP, Chief Medical Officer Anthony Quinn sold 7,500 shares of GEVA stock on 07/27/2012 at the average price of 50.2. Anthony Quinn owns at least 20,035 shares after this. The price of the stock has decreased by 2.87% since.
• SVP, Chief Medical Officer Anthony Quinn sold 2,500 shares of GEVA stock on 07/20/2012 at the average price of 50. Anthony Quinn owns at least 20,035 shares after this. The price of the stock has decreased by 2.48% since.

For the complete insider trading history of GEVA, click here.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool